Both medications are GLP-1 receptor agonists, but tirzepatide has the added advantage of mimicking another hormone, GIP, which enhances its impact on reducing appetite and increasing metabolism
It is already FDA-approved as a type 2 diabetes therapy and currently studied as a weight loss agent thanks to its potent appetite-suppressing and satiety-promoting effects
However, if you have a history of hypothermia, live in a cold climate, or are elderly, discuss cold sensitivity with your healthcare provider before starting semaglutide
The preservative maintains bacteriostatic activity through the 28-day use window specified in prescribing information, assuming refrigerated storage and proper aseptic technique on each puncture
Those speaking for the company believe there is reason to be optimistic that the clinical trial will show a synergistic benefit, in which the most significantly positive results will be seen in patients supplementing with a combination of the two ingredients
Moreover, tirzepatide was associated with a notably lower occurrence of the composite kidney outcome compared to insulin glargine
